… risk factors associated with atherosclerosis to provide novel … cytokines IL-10 and IL-1β
expression as well as serum levels of inflammatory proteins CRP, and COX-2, and atherosclerosis …

… The initial event in the development of atherosclerosis is endothelial injury. This causes …
with foam cells, release a variety of cytokines that promote inflammation and ROS generation. …

… atherosclerosis by secreting autoantibodies and cytokines that … This is achieved by releasing
chemokines and cytokines that … , thus accelerating the development of atherosclerosis [46]. …

… In addition, studies in experimental atherosclerosis models were extremely helpful in
evaluating a role of cytokines at different aortic regions and different stages of atherosclerosis. For …

… Chemokines, a family of chemoattractant cytokines, are stored in alpha granules in platelets.
However, the production of cytokines and other mediators, eg IL-1β take place in the cytosol…

In the beginning, atherosclerosis was considered to be the result of passive lipid accumulation
in the vascular walls. After tremendous technological advancements in research, we are …

… Inflammatory cytokines exacerbate and perpetuate atherosclerosis and attract more … The
inflammatory cytokine IL-1β is a proven therapeutic target to treat atherosclerosis. In mature …

… in atherosclerosis and laboratory results reported in severe COVID-19 infections, we hypothesized
a pathogenetic correlation. Atherosclerosis may … plasmatic concentration of cytokines. …

… cells in atherosclerosis is based … cytokines are attractive targets for developing new preventive
and therapeutic approaches including potential T cell-related therapies for atherosclerosis…

Over the past fifteen years, treatments using monoclonal antibodies specifically targeting
cytokines have been developed to treat chronic inflammatory diseases, including rheumatoid …